Diagnostics firm launches haematology analyser for mid-size labs

Clinical diagnostics company Beckman Coulter, has​ launched its DxH 690T haematology analyser.

Designed to help laboratories streamline workflow and maximise uptime, the DxH 690T offers the same features as the DxH 900 haematology analyser to mid-size labs, including a 93% first-pass yield and the recently released Early Sepsis Indicator.​

Peter Soltani, senior vice president and general manager of the haematology business unit at Beckman Coulter, said: “Laboratories are often called upon to do more with less—to balance growing testing demand with resource and cost pressures. The DxH 690T is a great solution for medium-sized laboratories to streamline workflow, report high confidence results and improve turnaround time by reducing procedural steps and manual touchpoints. It also supports standardization across hospital networks to a single platform—DxH 900 for larger labs and DxH 690T for medium labs.”

The DxH 690T analyser applies the company’s core haematology technologies—the enhanced Coulter Principle, VCS 360 and DataFusion—for high-resolution analysis of cells in their near native-states. This ensures medium-sized laboratories will achieve the right results the first time with no unnecessary reflex or repeats.

It also offers the Early Sepsis Indicator, which is available to automatically report as part of a routine CBC with white blood cell differential for adult patients in the emergency department. Affecting approximately 30 million people globally every year, early recognition of sepsis can be challenging. Beckman Coulter’s Early Sepsis Indicator is the only haematology-based biomarker FDA cleared specifically for augmenting the diagnosis of sepsis, so physicians can know sooner and act faster.

Soltani added: “Commercially available in most geographies today, the DxH 690T will be available globally in the​ next few months. The mid-volume instrument builds on our strength and history in haematology innovation, and complements our broad haematology portfolio including the award-winning DxH 520 for low-volume, the DxH 900 for high-volume and the DxH Connected Workcell Solutions for ultra-high-volume facilities.”

Back to topbutton